Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Hyponatremia and EGFR[original query] |
---|
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies. Annals of oncology : official journal of the European Society for Medical Oncology 2015 1 26 (5): 998-1005. Wong A L, Soo R A, Tan D S, Lee S C, Lim J S, Marban P C, Kong L R, Lee Y J, Wang L Z, Thuya W L, Soong R, Yee M Q, Chin T M, Cordero M T, Asuncion B R, Pang B, Pervaiz S, Hirpara J L, Sinha A, Xu W W, Yuasa M, Tsunoda T, Motoyama M, Yamauchi T, Goh B |
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study. BMC cancer 2018 Dec 18 (1): 1231. Tsutani Yasuhiro, Miyata Yoshihiro, Masuda Takeshi, Fujitaka Kazunori, Doi Mihoko, Awaya Yoshikazu, Kuyama Shoichi, Kitaguchi Soichi, Ueda Kazuhiro, Hattori Noboru, Okada Morihi |
Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study. Journal of thoracic disease 2017 Dec 9 (12): 5068-5074. Shen Qian, Dong Xiaoqi, Tang Xiaoping, Zhou Jianyi |
Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case report. Lung cancer (Amsterdam, Netherlands) 2022 3 166 132-134. Skribek Marcus, Bozoky Benedek, Tsakonas Georgi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: